The committee will be headed by Department of Pharmaceuticals Secretary V K Subburaj, and will have representatives from as many as 10 other departments or bodies.
"Pharmaceutical companies can approach this committee for whatever policy issues they are facing. They will be given immediate attention and all the issues can be addressed by this committee," Subburaj told PTI.
Also Read
The committee may also invite other government agencies/officials or representatives of industry and their associations to the meeting for more effective resolution of the pending issues.
Other members of the committee include representatives from various departments like department of industrial policy and promotion, commerce, science and technology, bio-technology, environment, health and family welfare and revenue.
Besides these, the committee will also have representatives from drug price regulator NPPA (National Pharmaceutical Pricing Authority) and Central Pollution Control Board. The Drug Controller General of India will also be a member of the committee.
Earlier, the task force in its report had suggested that the Department of Pharmaceuticals may come up with seed capital and facilitate funding with other financial institutions for the medium and small scale players in the pharmaceuticals industry.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)